Disclosure of the use of FasL antagonist, e.g. of humanized antibodies directed against human Fas Ligands (also named CD95L or Apo1L and hereinafter abbreviated as FasL) for the prevention and/or treatment of skin diseases associated with keratinocytes acantholysis, particularly for the prevention and/or treatment of pemphigus
Remedies for pemphigus containing anti Fas Ligand antibodies / Pincelli, Carlo; Marconi, Alessandra. - (2007 Dec 12).
Remedies for pemphigus containing anti Fas Ligand antibodies
PINCELLI, Carlo;MARCONI, Alessandra
2007
Abstract
Disclosure of the use of FasL antagonist, e.g. of humanized antibodies directed against human Fas Ligands (also named CD95L or Apo1L and hereinafter abbreviated as FasL) for the prevention and/or treatment of skin diseases associated with keratinocytes acantholysis, particularly for the prevention and/or treatment of pemphigusFile in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris